Come up with a name for your new list and we'll add to it:
Affinivax raised a round of funding on October 30, 2014. Investors include
Bill & Melinda Gates Foundation.
Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious disease…